The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic
In search of a selective therapy of viral infections
Current status and challenges of antiretroviral research and therapy
Early nucleoside reverse transcriptase inhibitors for the treatment of HIV: A brief history of stavudine (D4T) and its comparison with other dideoxynucleosides
Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine
Fifteen years of HIV Protease Inhibitors: raising the barrier to resistance
Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: A review of the last 20 years (1989–2009)
Entry inhibitors in the treatment of HIV-1 infection
Strand transfer inhibitors of HIV-1 integrase: Bringing IN a new era of antiretroviral therapy
Novel approaches to inhibiting HIV-1 replication
Development of topical microbicides to prevent the sexual transmission of HIV
Evaluation of antiretrovirals in animal models of HIV infection
Pharmacokinetics and drug–drug interactions of antiretrovirals: An update
Pharmacogenetics of antiretrovirals
Understanding and managing the adverse effects of antiretroviral therapy
Molecular basis of human immunodeficiency virus drug resistance: An update
Running a tightrope: Regulatory challenges in the development of antiretrovirals
The evolution of HIV treatment guidelines: Current state-of-the-art of ART
Clinical management of HIV-1 resistance
Update on antiretroviral therapy in paediatrics
Sexual transmission of HIV-1
HIV reservoirs, latency, and reactivation: Prospects for eradication
Effector mechanisms in HIV-1 infected elite controllers: Highly active immune responses?
Viral hepatitis and HIV co-infection